Alphatec Holdings, Inc. (ATEC), a leading medical technology firm specializing in spine surgery solutions, has demonstrated impressive financial growth and operational efficiency, positioning it as an attractive investment option for June. The company's recent first-quarter 2026 earnings report highlighted substantial improvements, including a 17% rise in surgical revenue and a 14% increase in overall revenue, reaching $192 million. This growth is underpinned by a 21% expansion in surgical case volume and a 23% growth in its surgeon user base, signaling strong market adoption of its innovative products.
Furthermore, Alphatec achieved a non-GAAP adjusted EBITDA of $21 million, marking a significant 460 basis point year-over-year expansion. Strategic financial management is also evident in the company's new bank facility, which is projected to reduce annual interest expenses by over $6 million and extend debt maturities until 2031. With a solid cash balance of $140 million and a trailing twelve-month free cash flow of $7 million, Alphatec is well-capitalized for future endeavors, despite adjusting expectations for its EOS business while maintaining confidence in its overall procedural ecosystem.
Looking ahead to the full year 2026, Alphatec projects robust financial performance, with an anticipated total revenue of approximately $882 million, reflecting a 15% growth rate, and surgical revenue expected to reach $805 million. The company aims for an adjusted EBITDA of roughly $134 million, equivalent to 15% of its revenue, and expects to generate at least $20 million in free cash flow. Alphatec's commitment to advancing surgical solutions and devices for spinal disorders, through innovative implants and tailored procedural solutions, underscores its potential for sustained success and positive impact on patient outcomes.
In the dynamic world of medical technology and investment, Alphatec stands out as a company that not only prioritizes innovation and patient well-being but also demonstrates strong financial acumen. Its continued growth and strategic financial decisions provide a compelling narrative of progress and potential. Investors seeking opportunities in a forward-thinking sector might find Alphatec's trajectory inspiring, as it continues to shape the future of spine surgery and deliver value.